Get started
Author

Heidi Peck

The Age-Specific Cumulative Incidence of Infection with Pandemic Influenza H1N1 2009 Was Similar in Various Countries Prior to Vaccination
2011 · Heath Kelly, Heidi A. Peck, et al. · PLoS ONE · 299
PDF
Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection
2015 · Yvonne C. F. Su, Justin Bahl, et al. · Nature Communications · 145
PDF
Evidence for the Introduction, Reassortment, and Persistence of Diverse Influenza A Viruses in Antarctica
2016 · Aeron C. Hurt, Yvonne C. F. Su, et al. · Journal of Virology · 81
PDF
Extended influenza seasons in Australia and New Zealand in 2025 due to the emergence of influenza A(H3N2) subclade K viruses
2025 · Clyde Dapat, Heidi Peck, et al. · Eurosurveillance · 45
PDF
Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season
2019 · Sheena G Sullivan, Carmen S Arriola, et al. · Eurosurveillance · 39
PDF
Influenza vaccination responses: Evaluating impact of repeat vaccination among health care workers
2017 · Vivian K.Y. Leung, Louise A. Carolan, et al. · Vaccine · 39
Intense interseasonal influenza outbreaks, Australia, 2018/19
2019 · Ian G Barr, Yi Mo Deng, et al. · Eurosurveillance · 34
PDF
Enhanced isolation of influenza viruses in qualified cells improves the probability of well-matched vaccines
2021 · Heidi Peck, Karen L. Laurie, et al. · npj Vaccines · 27
PDF
The re-emergence of influenza following the COVID-19 pandemic in Victoria, Australia, 2021 to 2022
2023 · Catherine GA Pendrey, Janet Strachan, et al. · Eurosurveillance · 21
PDF
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains
2025 · Caroline Kikawa, Andrea N. Loes, et al. · eLife · 19
Influenza A(H5N1) Virus Clade 2.3.2.1a in Traveler Returning to Australia from India, 2024
2024 · Yi-Mo Deng, Michelle Wille, et al. · Emerging infectious diseases · 18
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months
2022 · Francesca L. Mordant, Olivia H. Price, et al. · Influenza and Other Respiratory Viruses · 16
PDF
Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study
2024 · Joshua Nazareth, Christopher A. Martin, et al. · The Lancet Regional Health - Europe · 14
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025
2025 · Caroline Kikawa, John Huddleston, et al. · Virus Evolution · 12
PDF
Influenza Vaccination Strategies in Patients with Hematologic Cancer
2025 · Victoria G. Hall, Olivia C. Smibert, et al. · New England Journal of Medicine · 11
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2018
2020 · Olivia H Price, Natalie Spirason, et al. · Communicable Diseases Intelligence · 10
PDF
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2019
2021 · Heidi Peck, Jean Moselen, et al. · Communicable Diseases Intelligence · 9
PDF
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines
2025 · Wen Shi Lee, Kevin J. Selva, et al. · JCI Insight · 8
PDF
Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza
2023 · Hillary A. Vanderven, Deborah N. Wentworth, et al. · JCI Insight · 8
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2022
2023 · Tanya R Diefenbach-Elstob, Presa Chanthalavanh, et al. · Communicable Diseases Intelligence · 8
PDF
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020–2021
2020 · Genevieve O’Neill, Ammar Aziz, et al. · Communicable Diseases Intelligence · 8
PDF
Detection of Influenza in Managed Quarantine in Australia and the Estimated Risk of Importation
2022 · Heidi Peck, Nithila Anbumurali, et al. · Clinical Infectious Diseases · 7
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains
2025 · Caroline Kikawa, Andrea N Loes, et al. · eLife · 4
Influenza Vaccine Effectiveness in Australia During 2017–2019
2025 · Tanya Diefenbach‐Elstob, Monique B. Chilver, et al. · Influenza and Other Respiratory Viruses · 3
PDF
Influenza-Specific T-Cell Responses to Vaccination Are Independent of Underlying Hematological Malignancy: Analysis of a Randomized Influenza Vaccination Trial
2025 · Victoria G Hall, Thi H O Nguyen, et al. · The Journal of Infectious Diseases · 3
Works count: 46
Citation count: 898
H-index: 13
I10-index: 16
Year
Topic
Type